Back to search
Symptomatic Superficial Vein Thrombosis
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Symptomatic Superficial Vein Thrombosis trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Symptomatic Superficial Vein Thrombosis trials you may qualify forThis is a Phase III, randomized, placebo controlled, blinded, parallel two arm, multicentre trial that will compare rivaroxaban 10mg daily with placebo in patie…
To evaluate fondaparinux 2.5mg subcutaneously once daily for 45 days in the treatment of acute (recent) superficial thrombophlebitis.
We performed a national cross-sectional and prospective large epidemiological cohort study in patients with ST. Office- and hospital-based vascular medicine Fre…